354 related articles for article (PubMed ID: 32075665)
1. Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial.
Fernández Lucas M; Ruíz-Roso G; Merino JL; Sánchez R; Bouarich H; Herrero JA; Muriel A; Zamora J; Collado A
Trials; 2020 Feb; 21(1):206. PubMed ID: 32075665
[TBL] [Abstract][Full Text] [Related]
2. Initiating haemodialysis twice-weekly as part of an incremental programme may protect residual kidney function.
Kaja Kamal RM; Farrington K; Busby AD; Wellsted D; Chandna H; Mawer LJ; Sridharan S; Vilar E
Nephrol Dial Transplant; 2019 Jun; 34(6):1017-1025. PubMed ID: 30357360
[TBL] [Abstract][Full Text] [Related]
3. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
[TBL] [Abstract][Full Text] [Related]
4. IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients.
Deira J; Suárez MA; López F; García-Cabrera E; Gascón A; Torregrosa E; García GE; Huertas J; de la Flor JC; Puello S; Gómez-Raja J; Grande J; Lerma JL; Corradino C; Musso C; Ramos M; Martín J; Basile C; Casino FG
BMC Nephrol; 2019 Jan; 20(1):8. PubMed ID: 30626347
[TBL] [Abstract][Full Text] [Related]
5. Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial.
Kaja Kamal RM; Farrington K; Wellsted D; Sridharan S; Alchi B; Burton J; Davenport A; Vilar E
BMJ Open; 2020 Aug; 10(8):e035919. PubMed ID: 32792431
[TBL] [Abstract][Full Text] [Related]
6. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial.
Murea M; Moossavi S; Fletcher AJ; Jones DN; Sheikh HI; Russell G; Kalantar-Zadeh K
BMJ Open; 2021 May; 11(5):e047596. PubMed ID: 34031117
[TBL] [Abstract][Full Text] [Related]
7. The variable target model: a paradigm shift in the incremental haemodialysis prescription.
Casino FG; Basile C
Nephrol Dial Transplant; 2017 Jan; 32(1):182-190. PubMed ID: 27742823
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of DiPPI: A randomized controlled trial to evaluate the safety and effectiveness of progressive hemodialysis in incident patients.
Suárez MA; García-Cabrera E; Gascón A; López F; Torregrosa E; García GE; Huertas J; de la Flor JC; Puello S; Gómez-Raja J; Grande J; Lerma JL; Corradino C; Ramos M; Martín J; Basile C; Casino FG; Deira J
Nefrologia (Engl Ed); 2018; 38(6):630-638. PubMed ID: 30344012
[TBL] [Abstract][Full Text] [Related]
9. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.
Obi Y; Streja E; Rhee CM; Ravel V; Amin AN; Cupisti A; Chen J; Mathew AT; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
Am J Kidney Dis; 2016 Aug; 68(2):256-265. PubMed ID: 26867814
[TBL] [Abstract][Full Text] [Related]
10. Application of a pattern of incremental haemodialysis, based on residual renal function, when starting renal replacement therapy.
Merino JL; Domínguez P; Bueno B; Amézquita Y; Espejo B; Paraíso V
Nefrologia; 2017; 37(1):39-46. PubMed ID: 28212787
[TBL] [Abstract][Full Text] [Related]
11. The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial.
Hull KL; Bramham K; Brookes CL; Cluley V; Conefrey C; Cooper NJ; Eborall H; Fotheringham J; Graham-Brown MPM; Gray LJ; Mark PB; Mitra S; Murphy GJ; Quann N; Rooshenas L; Warren M; Burton JO
Trials; 2023 Aug; 24(1):522. PubMed ID: 37573352
[TBL] [Abstract][Full Text] [Related]
12. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.
Kalantar-Zadeh K; Unruh M; Zager PG; Kovesdy CP; Bargman JM; Chen J; Sankarasubbaiyan S; Shah G; Golper T; Sherman RA; Goldfarb DS
Am J Kidney Dis; 2014 Aug; 64(2):181-6. PubMed ID: 24840669
[TBL] [Abstract][Full Text] [Related]
13. Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.
Murea M; Patel A; Highland BR; Yang W; Fletcher AJ; Kalantar-Zadeh K; Dressler E; Russell GB
Am J Kidney Dis; 2022 Aug; 80(2):227-240.e1. PubMed ID: 34933066
[TBL] [Abstract][Full Text] [Related]
14. Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen.
Fernández-Lucas M; Teruel-Briones JL; Gomis-Couto A; Villacorta-Pérez J; Quereda-Rodríguez-Navarro C
Nefrologia; 2012; 32(6):767-76. PubMed ID: 23169359
[TBL] [Abstract][Full Text] [Related]
15. Incremental haemodialysis.
Wong J; Vilar E; Davenport A; Farrington K
Nephrol Dial Transplant; 2015 Oct; 30(10):1639-48. PubMed ID: 26038351
[TBL] [Abstract][Full Text] [Related]
16. The lacking equation that estimates the protein catabolic rate in patients on once-weekly haemodialysis.
Casino FG; Mostacci SD; Sabato A; Montemurro M; Procida C; Saracino A; Santarsia G; Basile C
J Nephrol; 2021 Apr; 34(2):459-464. PubMed ID: 33108604
[TBL] [Abstract][Full Text] [Related]
17. Comparison between incremental and thrice-weekly haemodialysis: Systematic review and meta-analysis.
Liu Y; Zou W; Wu J; Liu L; He Q
Nephrology (Carlton); 2019 Apr; 24(4):438-444. PubMed ID: 29532551
[TBL] [Abstract][Full Text] [Related]
18. Could incremental haemodialysis be a new standard of care? A suggestion from a long-term observational study.
Casino FG; Lopez T; Santarsia G; Mostacci SD; Sabato A; Di Carlo M; Procida C; Saracino A; Deira J; Basile C
G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819039
[No Abstract] [Full Text] [Related]
19. A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function.
Vilar E; Kaja Kamal RM; Fotheringham J; Busby A; Berdeprado J; Kislowska E; Wellsted D; Alchi B; Burton JO; Davenport A; Farrington K
Kidney Int; 2022 Mar; 101(3):615-625. PubMed ID: 34418414
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
